Fan Xiaoshan, Cheng Hongwei, Wang Xiaoyuan, Ye Enyi, Loh Xian Jun, Wu Yun-Long, Li Zibiao
Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, 453007, China.
Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.
Adv Healthc Mater. 2018 Apr;7(7):e1701143. doi: 10.1002/adhm.201701143. Epub 2017 Dec 27.
Pump mediated drug efflux is the key reason to result in the failure of chemotherapy. Herein, a novel star polymer β-CD-v-(PEG-β-PNIPAAm) consisting of a β-CD core, grafted with thermo-responsive poly(N-isopropylacrylamide) (PNIPAAm) and biocompatible poly(ethylene glycol) (PEG) in the multiple "V"-shaped arms is designed and further fabricated into supramolecular nanocarriers for drug resistant cancer therapy. The star polymer could encapsulate chemotherapeutics between β-cyclodextrin and anti-cancer drug via inclusion complex (IC). Furthermore, the temperature induced chain association of PNIPAAm segments facilitated the IC to form supramolecular nanoparticles at 37 °C, whereas the presence of PEG impart great stability to the self-assemblies. When incubated with MDR-1 membrane pump regulated drug resistant tumor cells, much higher and faster cellular uptake of the supramolecular nanoparticles were detected, and the enhanced intracellular retention of drugs could lead to significant inhibition of cell growth. Further in vivo evaluation showed high therapeutic efficacy in suppressing drug resistant tumor growth without a significant impact on the normal functions of main organs. This work signifies thermo-responsive supramolecular chemotherapy is promising in combating pump mediated drug resistance in both in vitro and in vivo models, which may be encouraging for the advanced drug delivery platform design to overcome drug resistant cancer.
泵介导的药物外排是导致化疗失败的关键原因。在此,设计了一种新型星形聚合物β-CD-v-(PEG-β-PNIPAAm),其由β-CD核心组成,在多个“V”形臂上接枝了热响应性聚(N-异丙基丙烯酰胺)(PNIPAAm)和生物相容性聚(乙二醇)(PEG),并进一步制备成用于耐药性癌症治疗的超分子纳米载体。该星形聚合物可通过包合物(IC)将化疗药物包裹在β-环糊精和抗癌药物之间。此外,PNIPAAm链段的温度诱导链缔合促进了IC在37℃形成超分子纳米颗粒,而PEG的存在赋予了自组装体很大的稳定性。当与MDR-1膜泵调节的耐药肿瘤细胞孵育时,检测到超分子纳米颗粒的细胞摄取更高、更快,并且药物在细胞内的保留增强可导致细胞生长的显著抑制。进一步的体内评估显示,在抑制耐药肿瘤生长方面具有高治疗效果,而对主要器官的正常功能没有显著影响。这项工作表明,热响应性超分子化疗在体外和体内模型中对抗泵介导的耐药性方面具有前景,这可能会鼓励设计先进的药物递送平台来克服耐药性癌症。